PrEP-related Patient Portal Perspectives

Overview:
Help us improve patient-provider messaging for HIV prevention! We are conducting a research study exploring how portal messaging can be adapted to better support Black and Latino gay, bi, and queer cisgender men’s use of PrEP, a pill or long-acting injectable that prevents HIV. You may be eligible if you currently use or are eligible to use PrEP, and if you have ever used a patient portal to communicate virtually with a health care provider.

Participation Details
🖥️ 1-hour virtual interview + 10-minute online survey
💳 Up to $70 compensation

Help improve patient-provider communication around PrEP—your insights matter!

Study Type:
Qualitative

IRB Approved:
Yes

Target Audience:
Black and Latino cisgender men who have sex with men

Target Audience:
20

How to Apply:
Use this link

Study Contact:
James Wolfe